![](/img/cover-not-exists.png)
Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening
Monica C. Robotin, Melanie Kansil, Kirsten Howard, Jacob George, Steven Tipper, Gregory J. Dore, Miriam Levy, Andrew G. PenmanVolume:
50
Year:
2009
Language:
english
DOI:
10.1016/j.jhep.2008.12.022
File:
PDF, 365 KB
english, 2009